TSA vs RSA in Glenohumeral Osteoarthritis
This study will compare total shoulder arthroplasty (TSA) reverse shoulder arthroplasty (RSA) procedures, in the context of a prospective, randomized-controlled trial to determine the optimal treatment in patients 65 years of age and older, and equal to or less than 15 degrees of glenoid retroversion, who have glenohum
| Condition(s) | Osteoarthritis of the Shoulder |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This study will compare total shoulder arthroplasty (TSA) reverse shoulder arthroplasty (RSA) procedures, in the context of a prospective, randomized-controlled trial to determine the optimal treatment in patients 65 years of age and older, and equal to or less than 15 degrees of glenoid retroversion, who have glenohumeral osteoarthritis. |
| Who can participate | Inclusion Criteria: 1. Patients who have failed standard non-surgical management of their idiopathic shoulder osteoarthritis who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for 6 months. Medical management will be defined as: 1. The use of drugs including analgesics and non-steroidal anti-inflammatory drugs 2. Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.) 3. Activity modification 2. Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss 3. Patients may present with a glenoid deficiency and \</=15 degrees of retroversion 4. 65 years of age and older Exclusion Criteria: 1. Act |
| Ages | 65 Years |
| Sex | All |
| Lead sponsor | Ottawa Hospital Research Institute |
| Locations | Edmonton, Alberta, Canada; Winnipeg, Manitoba, Canada; Kingston, Ontario, Canada; Ottawa, Ontario, Canada |
| Start date | 2020-03-09 |
| NCT ID | NCT04228419 |
| Official listing | https://clinicaltrials.gov/study/NCT04228419 |